Ketorolac Improves Graft Patency After Coronary Artery Bypass Grafting: A Propensity-Matched Analysis [ORIGINAL ARTICLES: ADULT CARDIAC]
Conclusions The use of ketorolac after coronary artery bypass grafting was associated with a lower rate of angiographically proven graft closure and suggests a mechanistic (improved graft patency) explanation for the previously reported survival benefit of ketorolac. (Source: The Annals of Thoracic Surgery)

Ketorolac: Keratitis and corneal melt following ophthalmic administration: case report
(Source: Reactions)div id=medwormpbiMedWorm Message:/i/b Please support the a href=http://www.doctorsinchains.org/ target=_blankDoctors In Chains/a campaign for the a href=http://www.doctorsinchains.org/medics/a tortured and sentenced for up to 15 years in a href=http://www.doctorsinchains.org/Bahrain/a. a href=https://twitter.com/#!/search/%23FreeDoctors#FreeDoctors/a/p/div